Any 0 3 0 3 O
condition 4 13 4 13 O
where 14 19 14 19 O
increased 20 29 20 29 O
venous 30 36 30 36 B-chronic_disease
and 37 40 37 40 I-chronic_disease
lymphatic 41 50 41 50 I-chronic_disease
return 51 57 51 57 O
is 58 60 58 60 O
undesirable 61 72 61 72 O

Diagnosis 0 9 73 82 O
of 10 12 83 85 O
active 13 19 86 92 O
or 20 22 93 95 O
recurrent 23 32 96 105 O
cancer 33 39 106 112 B-cancer
, 39 40 112 113 O
or 41 43 114 116 O
less 44 48 117 121 O
than 49 53 122 126 O
3 54 55 127 128 B-upper_bound
months 56 62 129 135 I-upper_bound
at 63 65 136 138 O
the 66 69 139 142 O
time 70 74 143 147 O
of 75 77 148 150 O
initial 78 85 151 158 O
evaluation 86 96 159 169 O
from 97 101 170 174 O
the 102 105 175 178 O
completion 106 116 179 189 O
of 117 119 190 192 O
chemotherapy 120 132 193 205 B-treatment
, 132 133 205 206 O
radiation 134 143 207 216 B-treatment
therapy 144 151 217 224 I-treatment
or 152 154 225 227 O
primary 155 162 228 235 O
surgery 163 170 236 243 B-treatment
for 171 174 244 247 O
the 175 178 248 251 O
treatment 179 188 252 261 O
of 189 191 262 264 O
cancer 192 198 265 271 O

Diagnosis 0 9 272 281 O
of 10 12 282 284 O
acute 13 18 285 290 B-chronic_disease
infection 19 28 291 300 I-chronic_disease

Diagnosis 0 9 301 310 O
of 10 12 311 313 O
acute 13 18 314 319 O
thrombophlebitis 19 35 320 336 B-chronic_disease
( 36 37 337 338 O
in 37 39 338 340 O
last 40 44 341 345 B-upper_bound
2 45 46 346 347 I-upper_bound
months 47 53 348 354 I-upper_bound
) 53 54 354 355 O

Diagnosis 0 9 356 365 O
of 10 12 366 368 O
chronic 13 20 369 376 B-chronic_disease
kidney 21 27 377 383 I-chronic_disease
disease 28 35 384 391 I-chronic_disease
with 36 40 392 396 O
a 41 42 397 398 O
Glomerular 43 53 399 409 B-clinical_variable
Filtration 54 64 410 420 I-clinical_variable
Rate 65 69 421 425 I-clinical_variable
( 70 71 426 427 I-clinical_variable
GFR 71 74 427 430 I-clinical_variable
) 74 75 430 431 I-clinical_variable
of 76 78 432 434 O
less 79 83 435 439 O
than 84 88 440 444 O
30 89 91 445 447 B-upper_bound
mls 92 95 448 451 I-upper_bound
per 96 99 452 455 I-upper_bound
minute 100 106 456 462 I-upper_bound

Diagnosis 0 9 463 472 O
of 10 12 473 475 O
congestive 13 23 476 486 B-chronic_disease
heart 24 29 487 492 I-chronic_disease
failure 30 37 493 500 I-chronic_disease
( 38 39 501 502 O
uncontrolled 39 51 502 514 O
) 51 52 514 515 O

Diagnosis 0 9 516 525 O
of 10 12 526 528 O
peripheral 13 23 529 539 B-chronic_disease
arterial 24 32 540 548 I-chronic_disease
disease 33 40 549 556 I-chronic_disease
( 41 42 557 558 I-chronic_disease
PAD 42 45 558 561 I-chronic_disease
): 45 47 561 563 I-chronic_disease
PAD 48 51 564 567 O
is 52 54 568 570 O
defined 55 62 571 578 O
as 63 65 579 581 O
an 66 68 582 584 O
Ankle 69 74 585 590 B-clinical_variable
Brachial 75 83 591 599 I-clinical_variable
Index 84 89 600 605 I-clinical_variable
( 90 91 606 607 I-clinical_variable
ABI 91 94 607 610 I-clinical_variable
) 94 95 610 611 I-clinical_variable
, 95 96 611 612 O
of 97 99 613 615 O
0.7 100 103 616 619 B-upper_bound
or 104 106 620 622 O
lower 107 112 623 628 O

Diagnosis 0 9 629 638 O
of 10 12 639 641 O
pulmonary 13 22 642 651 B-chronic_disease
edema 23 28 652 657 I-chronic_disease

Diagnosis 0 9 658 667 O
of 10 12 668 670 O
pulmonary 13 22 671 680 B-chronic_disease
embolism 23 31 681 689 I-chronic_disease
or 32 34 690 692 O
deep 35 39 693 697 B-chronic_disease
vein 40 44 698 702 I-chronic_disease
thrombosis 45 55 703 713 I-chronic_disease
within 56 62 714 720 O
the 63 66 721 724 O
previous 67 75 725 733 B-upper_bound
6 76 77 734 735 I-upper_bound
months 78 84 736 742 I-upper_bound

Patients 0 8 743 751 O
with 9 13 752 756 O
poorly 14 20 757 763 O
controlled 21 31 764 774 O
asthma 32 38 775 781 B-chronic_disease
( 39 40 782 783 O
i.e. 40 44 783 787 O
those 45 50 788 793 O
with 51 55 794 798 O
severe 56 62 799 805 O
persistent 63 73 806 816 O
symptoms 74 82 817 825 O
throughout 83 93 826 836 O
the 94 97 837 840 O
day 98 101 841 844 O
, 101 102 844 845 O
night 103 108 846 851 O
time 109 113 852 856 O
awakenings 114 124 857 867 O
several 125 132 868 875 O
times 133 138 876 881 O
per 139 142 882 885 O
week 143 147 886 890 O
, 147 148 890 891 O
use 149 152 892 895 O
of 153 155 896 898 O
a 156 157 899 900 O
beta2 158 163 901 906 B-treatment
agonist 164 171 907 914 I-treatment
inhaler 172 179 915 922 I-treatment
several 180 187 923 930 O
times 188 193 931 936 O
per 194 197 937 940 O
day 198 201 941 944 O
and 202 205 945 948 O
those 206 211 949 954 O
whose 212 217 955 960 O
normal 218 224 961 967 O
activity 225 233 968 976 O
is 234 236 977 979 O
extremely 237 246 980 989 O
limited 247 254 990 997 O
) 254 255 997 998 O

Pregnancy 0 9 999 1008 B-pregnancy

The 0 3 1009 1012 O
source 4 10 1013 1019 O
of 11 13 1020 1022 O
the 14 17 1023 1026 O
infection 18 27 1027 1036 O
must 28 32 1037 1041 O
be 33 35 1042 1044 O
treated 36 43 1045 1052 O
for 44 47 1053 1056 O
2 48 49 1057 1058 B-upper_bound
weeks 50 55 1059 1064 I-upper_bound
prior 56 61 1065 1070 I-upper_bound
to 62 64 1071 1073 O
admittance 65 75 1074 1084 O

have 0 4 1085 1089 O
a 5 6 1090 1091 O
diagnosis 7 16 1092 1101 O
of 17 19 1102 1104 O
primary 20 27 1105 1112 B-cancer
or 28 30 1113 1115 I-cancer
secondary 31 40 1116 1125 I-cancer
late 41 45 1126 1130 I-cancer
Stage 46 51 1131 1136 I-cancer
2 52 53 1137 1138 I-cancer
or 54 56 1139 1141 I-cancer
3 57 58 1142 1143 I-cancer
unilateral 59 69 1144 1154 I-cancer
or 70 72 1155 1157 I-cancer
bilateral 73 82 1158 1167 I-cancer
lower 83 88 1168 1173 I-cancer
extremity 89 98 1174 1183 I-cancer
lymphoedema 99 110 1184 1195 I-cancer

â‰¥ 0 1 1196 1197 O
18 2 4 1198 1200 B-lower_bound
years 5 10 1201 1206 I-lower_bound
old 11 14 1207 1210 O
or 15 17 1211 1213 O
legal 18 23 1214 1219 O
age 24 27 1220 1223 B-age
in 28 30 1224 1226 O
host 31 35 1227 1231 O
country 36 43 1232 1239 O

